Strategic collaboration aims to expand treatment options, improve patient outcomes
CHICAGO (November 3, 2021) — The Society of Thoracic Surgeons (STS) has entered into a partnership with biopharmaceutical company AstraZeneca in an effort to advance and improve lung cancer treatment and eliminate disparities in health care.
This partnership will help facilitate a series of educational programs that range from conducting advanced skills courses to helping early career surgeons design optimal clinical trials.